Form 4: PBH Director Sheila Hopkins Receives RSU Grant

Prestige Consumer Healthcare Inc. director Sheila Hopkins received 2,094 restricted stock units valued at $155,000 as part of the company's director compensation program.

Summary

• Sheila Hopkins, a Director of Prestige Consumer Healthcare Inc. (PBH), acquired 2,094 restricted stock units (RSUs).
• The transaction occurred on August 5, 2025.
• The RSUs were granted as part of the Issuer's director compensation program.
• The value of the grant was $155,000, calculated based on the closing stock price of $74.04 on August 5, 2025.
• The RSUs vest on the first anniversary of the grant date.
• Settlement will occur upon the earliest of the Reporting Person's death, separation, or a change in control.
• Following this transaction, Sheila Hopkins beneficially owns 30,123 shares of common stock.

Sentiment

Score: 7

Explanation: The filing indicates a routine, positive event of director compensation through equity, aligning interests. It's a standard corporate action with no negative implications.

Positives

• Grant of restricted stock units aligns director interests with shareholder value through equity compensation.
• The compensation program helps attract and retain qualified board members.

Future Outlook

The restricted stock units are set to vest on the first anniversary of the grant date, with settlement occurring upon the earliest of the Reporting Person's death, separation from service, or a change in control of the company.

Industry Context

This transaction represents a standard equity compensation practice for directors in publicly traded companies, aligning their long-term interests with shareholder value. Such grants are common across various industries, particularly in consumer healthcare, to incentivize board oversight and strategic guidance.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a common practice in corporate governance, aligning director incentives with long-term shareholder value.
• While specific compensation amounts vary by company size and industry, equity-based compensation is a standard component of director remuneration across the S&P 500.
• Similar practices are observed in companies like Johnson & Johnson (JNJ) or Procter & Gamble (PG), where directors often receive a mix of cash and equity awards, including RSUs, to foster commitment and performance.

Corporate Governance

Stakeholder Impact

• Shareholders: Interests are further aligned with the director through equity compensation, potentially leading to more focused long-term decision-making.

Next Steps

• The restricted stock units will vest on the first anniversary of the grant date (August 5, 2026).
• Settlement of the vested RSUs will occur upon the earliest of the Reporting Person's death, separation from service, or a change in control.

Key Dates

Recommendation

This Form 4 filing reports a routine equity compensation grant to a director, which is a standard corporate governance practice. It does not provide new information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction aligns director interests with shareholders but does not present a catalyst for significant price movement or a re-evaluation of the company's fundamentals.

Keywords

Prestige Consumer Healthcare, PBH, Sheila Hopkins, Form 4, SEC Filing, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Insider Transaction